期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間：約Review Process, 7.2 weeks; Acceptance to First Online, 0.7 weeks Review Process, 7.2 weeks; Acceptance to First Online, 0.7 weeks 約7.2 weeks

Biomaterials Advances, previously known as Materials Science and Engineering: C-Materials for Biological Applications (P-ISSN: 0928-4931, E-ISSN: 1873-0191). Includes topics at the interface of the biomedical sciences and materials engineering. These topics include:

? Bioinspired and biomimetic materials for medical applications

? Materials of biological origin for medical applications

? Materials for "active" medical applications

? Self-assembling and self-healing materials for medical applications

? "Smart" (i.e., stimulus-response) materials for medical applications

? Ceramic, metallic, polymeric, and composite materials for medical applications

? Materials for in vivo sensing

? Materials for in vivo imaging

? Materials for delivery of pharmacologic agents and vaccines

? Novel approaches for characterizing and modeling materials for medical applications

Manuscripts on biological topics without a materials science component, or manuscripts on materials science without biological applications, will not be considered for publication in Materials Science and Engineering C. New submissions are first assessed for language, scope and originality (plagiarism check) and can be desk rejected before review if they need English language improvements, are out of scope or present excessive duplication with published sources.

Biomaterials Advances sits within Elsevier's biomaterials science portfolio alongside Biomaterials, Materials Today Bio and Biomaterials and Biosystems. As part of the broader Materials Today family, Biomaterials Advances offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!

《生物材料進(jìn)展》，原名為《材料科學(xué)與工程：生物應(yīng)用的 C 材料》（P-ISSN：0928-4931，E-ISSN：1873-0191）。包括生物醫(yī)學(xué)科學(xué)與材料工程交叉領(lǐng)域的主題。這些主題包括：

? 用于醫(yī)療應(yīng)用的生物啟發(fā)和仿生材料

? 用于醫(yī)療應(yīng)用的生物來(lái)源材料

? 用于“主動(dòng)”醫(yī)療應(yīng)用的材料

? 用于醫(yī)療應(yīng)用的自組裝和自修復(fù)材料

? 用于醫(yī)療應(yīng)用的“智能”（即刺激-反應(yīng)）材料

? 用于醫(yī)療應(yīng)用的陶瓷、金屬、聚合物和復(fù)合材料

? 用于體內(nèi)傳感的材料

? 用于體內(nèi)成像的材料

? 用于藥劑和疫苗輸送的材料

? 用于醫(yī)療應(yīng)用的材料表征和建模的新方法

沒(méi)有材料科學(xué)成分的生物學(xué)主題手稿或沒(méi)有生物學(xué)應(yīng)用的材料科學(xué)手稿將不考慮在材料科學(xué)與工程 C 上發(fā)表。新提交的文章首先會(huì)根據(jù)語(yǔ)言、范圍和原創(chuàng)性（抄襲檢查），如果需要改進(jìn)英語(yǔ)語(yǔ)言、超出范圍或與已發(fā)表的資料存在過(guò)多重復(fù)，則可在審查前被拒絕。

Biomaterials Advances 與 Biomaterials、Materials Today Bio 和 Biomaterials and Biosystems 一起屬于 Elsevier 的生物材料科學(xué)組合。作為更廣泛的 Materials Today 家族的一部分，Biomaterials Advances 為作者提供嚴(yán)格的同行評(píng)審、快速?zèng)Q策和高知名度。我們期待收到您的投稿！

《Biomaterials Advances》(生物材料進(jìn)展)編輯部通訊方式為ELSEVIER, RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。